Detection of rare CTCs by electrochemical biosensor built on quaternary PdPtCuRu nanospheres with mesoporous architectures
Xi Zhou,Dan Bai,Hongyan Yu,Yixin Fu,Lin Song,You Wu,Kena Chen,Junjie Li,Yujun Yang,Huajian Chen,Zhongzhong Wang,Guoming Xie,Xi Zhou,Dan Bai,Hongyan Yu,Yixin Fu,Lin Song,You Wu,Kena Chen,Junjie Li,Yujun Yang,Huajian Chen,Zhongzhong Wang,Guoming Xie
DOI: https://doi.org/10.1016/j.talanta.2022.123955
IF: 6.1
2023-02-01
Talanta
Abstract:Circulating tumor cells (CTCs) are promising liquid biopsy biomarkers for early cancer detection and anti-cancer therapy evaluation. The ultra-low abundance of CTCs in blood samples requires highly sensitive and accurate detection ways. In this study, we propose the design of a dual-recognition electrochemical biosensor to improve both the specificity and signal response. PdPtCuRu mesoporous nanospheres (PdPtCuRu MNSs) with excellent three dimensions (3D) nanopore structures were synthesized by one-pot method and connected to mucin 1 (MUC1) aptamer to serve as signal amplification probe. Besides, superconductive carbon black, Ketjen Black (KB), and gold nanoparticles (AuNPs) modified organometallic frame (CeMOF-Au) were combined to work as signal transducer. The characteristic branching structure of KB provides abundant contact points to load CeMOF-Au to heighten the interface electron transfer rate. In addition, AuNPs were reduced on the surface of CeMOF, which could effectively bind the capture antibody and further enhance the conductivity. Under the optimized condition, the limit of detection (LOD) of the as-constructed biosensor was less than 10 cells mL−1 for model A549 cells, and showed good specificity and accuracy in spiked serum samples. We envision the as-proposed electrochemical biosensor would alternate as a useful tool for the clinical detection of CTCs for cancer diagnosis.
chemistry, analytical